Jun 2024 New Nitazene Data – Ongoing Evaluation of an Emerging Threat
Gabapentin (Neurontin, Gralise, Horizant) was first approved by the US Food and Drug Administration (FDA) in 1993 for the treatment...
Clinical Update
30 May The Center for Forensic Science Research & Education (CFSRE) Publishes An Alert Regarding 2F-2oxo-PCE
in
News
On May 30, 2024, The Center for Forensic Science Research & Education (CFSRE) published an alert regarding 2F-2oxo-PCE...
22 May Aegis Clinical Team Members Discuss the Dangers of Tianeptine Misuse with Drug Topics Magazine
in
News
Aegis Sciences Corporation, a health care testing lab based in Nashville, TN, recently had two members of its Clinical Team...
20 May Medetomidine “Rapidly Proliferating Across USA”
in
News
On May 20, 2024, the Center for Forensic Science Research & Education (CFSRE), a leading organization within the United States...
Apr 2024 Novel Psychoactive Substance Trends in 2023
Novel Psychoactive Substances (NPS) are a diverse group of synthetic substances created to mimic the effects of prescription or illicit...
01 Apr Aegis Sciences Corporation Announces Updates for NPS Testing
in
News
NASHVILLE, TN. (April 1, 2024) – Aegis Sciences Corporation, a health care testing lab based in Nashville, TN, is pleased to announce...
